EVs from glioma patients have been shown to be a source for the detection of clinically relevant prognostic biomarkers, such as IDH1-R132H and EGFRvIII, and have been successfully extracted from blood and CSF [14,21,22,23,24]. This evidence concerns the gene IDH1 and glioma.